Each abstract program is designed to highlight excellence across various stages of dermatologic research. Please refer to the tabs below for detailed information on each abstract program, including ...

Major histocompatibility complex (MHC, human leukocyte antigen [HLA] in humans) class I molecules present peptides at the cell surface to cytotoxic immune cells. Peptides are generated and selected ...

NEW TAIPEI CITY, Taiwan, Oct. 20, 2025 /PRNewswire/ -- GlycoNex, Inc. (4168, hereinafter referred to as GNX), a clinical stage biotechnology company focused on the development of glycan-directed ...

When one accesses the getExtensions() method of an abstract class that implements ExtensionAware a java.lang.NoSuchMethodError is thrown. The conditions for this to ...

TScan Therapeutics announced an accepted abstract for poster presentation at ASGCT's annual meeting on TCR-engineered therapies for cancer. TScan Therapeutics, Inc., a clinical-stage biotechnology ...

Please review the following abstract policies when preparing your submission. You can also review the Abstract Policy FAQs page for answers to common questions asked by submitters.

A local artist will be hosting a painting class on Sunday that also will include light snacks and a beverage. Penne Williams said will be taking a more personal approach for her art class rather than ...

Royalty-free licenses let you pay once to use copyrighted images and video clips in personal and commercial projects on an ongoing basis without requiring additional payments each time you use that ...

AND017 is a first-in-class hemoglobin elevating agent (HbEA) that targets multiple stages of the red blood cell (RBC) life cycle and is being developed to treat anemia associated with ...

Monopar Therapeutics Inc. today announced that its abstract titled “Evaluation of Anti-uPAR Antibody as a Radiopharmaceutical for Imaging and Treatment of Solid Tumors” has been accepted as a ...